Deoxynucleoside Analogs In Cancer Therapy

1. Nucleoside Transport Into Cells
Marçal Pastor-Anglada, F. Javier Casado

2. The Role of Deoxycytidine Kinase in DNA Synthesis and Nucleoside Analog Activation
Maria Staub, Staffan Eriksson

3. Deoxynucleoside Kinases and Their Potential Role in Deoxynucleoside Cytotoxicity
Birgitte Munch-Petersen, Jure Piškur

4. Nucleotidases and Nucleoside Analog Cytotoxicity
Sally Anne Hunsucker, Beverly S. Mitchell, Jozef Spychala

5. Pumping Out Drugs
Piet Borst, Peter Wielinga

6. Cytosine Arabinoside
Isabelle Hubeek, Gert-Jan L. Kaspers, Gert J. Ossenkoppele, Godefridus J. Peters

7. Clofarabine
Varsha Gandhi, William Plunkett

8. L-Nucleosides as Chemotherapeutic Agents
Giuseppe Gumina, Youhoon Chong, Chung K. Chu

9. Troxacitabine (Troxatyl ™)
Henriette Gourdeau, Jacques Jolivet

10. 9-ß-D-Arabinofuranosylguanine
Sophie Curbo, Anna Karlsson

11. Gemcitabine
Andries M. Bergman, Godefridus J. Peters

12. Clinical Activity of Gemcitabine as a Single Agent and in Combination
Judith R. Kroep, Godefridus J. Peters, Robert A. Nagourney

13. Nucleoside Radiosensitizers
Donna S. Shewach, Theodore S. Lawrence

14. NONMEM Population Models of Cytosine Arabinoside and Fludarabine Phosphate in Pediatric Patients With Leukemia
Vassilios I. Avramis

15. ThecycloSal-Nucleotide Delivery System
Chris Meier, Jan Balzarini, Astrid Meerbach

16. Purine and Pyrimidine-Based Analogs and Suicide Gene Therapy
Zoran Gojkovic, Anna Karlsson

17. 3'-Deoxy-3'-Fluorothymidine as a Tracer of Proliferation in Positron Emission Tomography
Wieteke G. E. Direcks, Adriaan A. Lammertsma, Carla F. M. Molthoff

DRM-restrictions

Printing: not available
Clipboard copying: not available

Nyckelord: TECHNOLOGY & ENGINEERING / Biomedical TEC059000